|
|
Article: Photodynamic cell therapy may help prevent graft-versus-host disease.
- Article from:
- Blood Weekly
- Article date:
- May 30, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 MAY 30 - (NewsRx.com & NewsRx.net) -- Collaborators of Celmed BioSciences, a subsidiary of Theratechnologies, published groundbreaking results in the May 1, 2002, issue of Blood, the journal of the American Society of Hematology (ASH).
The study suggests that a photodynamic cell therapy process (PDT) can selectively deplete host alloantigen-specific T cells to prevent graft-versus-host disease (GvHD), while preserving immune and antileukemia functions.
The research was conducted by researchers from the bone marrow transplantation program at Duke University Medical Center in Durham, North Carolina.
The researchers demonstrated in a mouse ...